Kraws Jeffrey J has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 75000 shares of Theriva Biologics, Inc. ($TOVX) on January 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Theriva Biologics, Inc. | $TOVX | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 75000 | $0.00 | 75,000.0000 | 9,676,521 | 9999.99% | 0.78% |
| April 29, 2025 | Theriva Biologics, Inc. | $TOVX | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 2,782,449 | 9999.99% | 0.90% |
| Dec. 14, 2023 | Theriva Biologics, Inc. | $TOVX | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 110000 | $0.00 | 110,000.0000 | 681,708 | 9999.99% | 16.14% |